Swissmedic to investigate safety of Bayer's contraceptive Yaz
This article was originally published in Scrip
Executive Summary
Swissmedic, Switzerland's medicines regulator, is to further investigate Bayer's oral contraceptive pill Yaz (drospirenone plus ethinylestradiol) following the sudden death of a young woman there in mid-September.